Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

MUN/4DN stock hub

MUN/4DN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MUN/4DNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6B

Munich Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

MUN/4DN

In the news

Latest news · MUN/4DN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-49.6

P25 n/aP50 n/aP75 n/a

ROIC-357.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MUN/4DN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

144

Groups with data

Currency

USD

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	503
Employees Change	127%
Employees Change Percent	32.56
Enterprise value	EUR 1.8B
Exchange	Munich Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 2.6B
Price	EUR 17.47
Price currency	EUR
Sic	2836
Symbol	mun/4DN
Website	https://www.denalitherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.66%
EV Earnings	-4.03x
EV/FCF	-4.89x
FCF yield	-13.75%
P/B ratio	3.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -363.2M
Net Income	EUR -440.6M
Profit Per Employee	EUR -875,951
ROA	-26.95
Roa5y	-17.79
ROCE	-47.33
ROE	-49.59
Roe5y	-31.43
ROIC	-357.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	37.98%
Cagr3y	-10.45%
Cagr5y	-16.38%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 1.1B
Cash	EUR 856.6M
Current Assets	EUR 763.7M
Current Liabilities	EUR 83.4M
Debt	EUR 26.2M
Debt Equity	EUR 0.03
Debt FCF	EUR -0.07
Equity	EUR 803.2M
Liabilities	EUR 294.8M
Long Term Assets	EUR 334.3M
Long Term Liabilities	EUR 211.4M
Net Cash	EUR 885.8M
Net Cash By Market Cap	EUR 33.49
Net Cash Growth	-18.77%
Net Debt Equity	EUR -1.1
Tangible Book Value	EUR 772M
Tangible Book Value Per Share	EUR 4.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.28
Net Working Capital	EUR -65.1M
Quick ratio	8.97
Working Capital	EUR 791.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	37.95%
200-day SMA	33.3
3Y total return	-28.19%
50-day SMA	16.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-59.11%
All Time High	76.28
All Time High Change	-77.1%
All Time High Date	2020-12-23
All Time Low	10.8
All Time Low Change	61.71%
All Time Low Date	2018-07-31
ATR	1.13
Ch YTD	1.51
High	17.47
High52	19.54
High52 Date	2026-02-03
High52ch	-10.62%
Low	17.31
Low52	10.92
Low52 Date	2025-09-22
Low52ch	60.01%
Ma50ch	3.34%
Price vs 200-day SMA	-47.55%
RSI	53.55
RSI Monthly	47.26
RSI Weekly	42.76
Sharpe ratio	-0.59x
Sortino ratio	-0.81
Total Return	-4.97%
Tr YTD	1.51
Tr1m	3.87%
Tr1w	2.68%
Tr3m	-10.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -474.5M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144,239,769%
Net Borrowing	-6,926,153.6
Shares Insiders	4.59%
Shares Institutions	99.01%
Shares Qo Q	1.76%
Shares Yo Y	4.97%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -448.2M
Average Volume	101.6x
Bv Per Share	5.06
CAPEX	EUR -6M
Ch1m	3.87
Ch1w	2.68
Ch1y	37.95
Ch3m	-10.62
Ch3y	-28.19
Ch5y	-59.11
Ch6m	32.71
Change	2.67%
Change From Open	0.92
Close	17.01
Days Gap	1.73
Depreciation Amortization	12,560,013.1
Dollar Volume	87.33
Earnings Date	2026-05-13
EBIT	EUR -474.5M
EBITDA	EUR -461.2M
EPS	EUR -2.5
F Score	2
FCF	EUR -363.6M
FCF EV Yield	-20.46x
Financing CF	357,346,681
Fiscal Year End	December
Founded	2,013
Income Tax	EUR 88,465
Investing CF	287,070,229
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	27.19
Ma150ch	-35.76%
Ma20	16.17
Ma20ch	8%
Net CF	286,797,897
Next Earnings Date	2026-05-13
Open	17.31
Position In Range	100
Ppne	101,700,322.5
Price Date	2026-05-07
Ptbv Ratio	3.43
Relative Volume	0.05x
Share Based Comp	84,613,788
Tr6m	32.71%
Volume	5

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MUN/4DN pay a dividend?

Capital-return profile for this ticker.

Performance

MUN/4DN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MUN/4DN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+99.0%

Share of float held by funds and institutions

Insider ownership

+4.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.0%

Negative means the company is buying back shares.

Technical

MUN/4DN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.6

Neutral momentum band

Price vs 200-day MA

-47.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MUN/4DN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current mun/4DN stock rating?

mun/4DN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full mun/4DN analysis?

The full report lives at /stocks/mun/4DN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for mun/4DN?

The latest report frames mun/4DN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the mun/4DN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.